Westmore · UDRP DecisionLundbeckpsychiatry.org
The Panel ordered transfer of lundbeckpsychiatry.org after finding it confusingly similar to the LUNDBECK trademark, that the Respondent lacked rights or legitimate interests, and that the domain was registered and used in bad faith.
The timeline behind lundbeckpsychiatry.org
Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.
Westmore reconstructs the full history behind lundbeckpsychiatry.org — from public RDAP and the Internet Archive — as part of UDRP Intelligence:
The Respondent intentionally registered a domain reproducing the long-established LUNDBECK mark together with a term related to the Complainant’s activity, making lack of knowledge unlikely. The Panel also relied on apparently non-genuine website contact information, the failure to respond, and use of a privacy shield.
Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.
Case number CAC-UDRP-101905 Time of filing 2018-02-27 09:18:19 Domain names lundbeckpsychiatry.org Case administrator Organization Iveta Špiclová (Czech Arbitration Court) (Case admin) Complainant Organization H. Lundbeck A/S Complainant representative Organization Wallberg IP Advice Respondent Organization Suso Webmaster Other Legal Proceedings The Panel is not aware of any other legal proceedings pending or decided between the same parties and relating to the Disputed Domain Name. Identification Of Rights The Complainant is the registered owner of many trademark registrations consisting of the term “LUNDBECK” in more than 100 countries around the world in particular European Union trademark no. 1147485 registered on 14.12.2011 for goods and services in classes 5, 9, 10, 16, 35, 40, 41, 42 and 44. Factual Background FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT: The Complainant was founded in 1915 and is an international pharmaceutical company engaged - also through its official website www.lundbeck.com - in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases. It is one of the world's leading pharmaceutical companies working with brain disorders and employs approximately 5.000 people worldwide. In 2016, its revenue was USD 2.5 billion. It markets a number of different pharmaceuticals for the treatment of brain disorders. The Complainant further contends the distinctiveness and intensive use of its trademarks. The Disputed Domain Name <lundbeckpsychiatry.org> was created on 24.05.2017 and resolves to a website that contains information on and promote services related to “COMMON PROBLEMS OF WATER HEATER IN APARTMENTS AND HOW TO PREVENT SUCH PROBLEMS”. Parties Contentions NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED. Rights The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy). No Rights or Legitimate Interests The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy). Bad Faith The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy). Procedural Factors The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision. Principal Reasons for the Decision 1. The Panel finds that the Disputed Domain Name is confusingly similar to the Complainant’s trademark. Many Panels have found that a Disputed Domain Name is confusingly similar to a Complainant’s trademark where the Disputed Domain Name incorporates the Complainant’s trademark in its entirety. This is the case in the case at issue where the Complainant’s registered trademark “LUNDBECK” is fully included in the Disputed Domain Name followed by the generic term “PSYCHIATRY”, which is related to the Complainant’s business activity and is likely to increase the possibility of confusion amongst consumers. 2. In the absence of any Response, or any other information from the Respondent indicating the contrary, the Panel further holds that the Complainant successfully presented its prima facie case and that the Respondent has no rights or legitimate interests in respect of the Disputed Domain Name. In particular, the Respondent is not affiliated with nor authorized by the Complainant in any way, and he is not related in any way to the Complainant’s business. In addition, the Respondent is not commonly known by the Disputed Domain Name. Finally, the Disputed Domain Name resolved to a website containing information on water heaters. This Panel finds that the Respondent failed to provide a credible explanation for its choice of the Disputed Domain Name. Such use can neither be considered as bona fide offering of goods or services nor a legitimate non-commercial or fair use of the Disputed Domain Name, without intent for commercial gain to misleadingly divert consumers or to tarnish the trademark or service mark at issue. 3. Finally, the Panel finds that the Disputed Domain Name has been registered and is being used in bad faith. It is the view of this Panel that the Respondent has intentionally registered the Disputed Domain Name which totally reproduces the trademark “LUNDBECK” of the Complainant, that has been established many decades ago. Moreover, this trademark is followed by the generic term “PSYCHIATRY”, which is related to the Complainant’s area of activity. By the time the Disputed Domain Name was registered, it is unlikely that the Respondent did not have knowledge of the Complainant’s rights on its trademark. In addition, the Respondent used the Disputed Domain Name to lead to a website where it is unlikely that the claimed services are genuinely offered, since the contact information provided in the website seems not to be genuine. These facts, including the failure to submit a response, the privacy shield to hide the Respondent’s identity, also confirm that the Disputed Domain Name has been registered and is being used in bad faith. For all the reasons stated above, the Complaint is Accepted and the disputed domain name(s) is (are) to be LUNDBECKPSYCHIATRY.ORG: Transferred PANELLISTS Name Dr. Federica Togo Date of Panel Decision 2018-05-09 Publish the Decision
Source of record: CAC . Reproduced for research; CAC is the authoritative source.
What Westmore sees around lundbeckpsychiatry.org
The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.
Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.
The decision is only the beginning.
You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.
Go beyond the public record: see how this case has been cited, find comparable decisions, analyze the panelist and apply the relevant authorities to your Matter.
Westmore Professional · $395/month
Research with UDRP IntelligenceWestmore AI drafts an attorney-review-ready UDRP response from your facts, grounded in the exact panel and closest precedent.
$895 one-time per matter · no subscription required. Self-help drafting aid — not legal advice.
Build your responseWestmore UDRP records draw on CAC-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.